-
Dr. Kaixiong Tao: Winning in Integrated Oncology Treatment, Striving to Be the “Internist with a Scalpel” | 2024 CACA
The 2024 CACA Integrative Gastric Cancer Conference was held in Wuhan from October 18-19, bringing together domestic and international experts across multiple disciplines in gastric cancer. Oncology Frontier had the privilege to interview Dr. Kaixiong Tao, Executive Chair of this year’s conference and Professor from Wuhan Union Hospital of China. Prof. Tao discussed the core…
-
HAIC Revolutionizes Postoperative Adjuvant Therapy for Liver Cancer, Focusing on Patient Survival and Quality of Life | IHBC 9th Academic Symposium
From October 24-27, 2024, the 9th Academic Symposium of the International Hepato-Pancreato-Biliary Association (IHPBA) China Chapter took place in Wuhan. In the field of liver cancer adjuvant therapy, Dr. Minshan Chen from the Sun Yat-sen University Cancer Center presented new treatment strategies. Oncology Frontier invited Prof. Chen for an in-depth interview, where he shared insights…
-
ILCA 2024 | Dr. Guohong Han: Exploring Advances and Prospects in Liver Cancer Treatment
Liver cancer is a major global health threat, and ongoing exploration into treatment strategies remains a focal point in medical research. From October 17 to 19, 2024, top experts and scholars in the field of liver cancer gathered in Toronto, Canada, for the 18th International Liver Cancer Association (ILCA) Annual Meeting. This conference brought together…
-
Dr. Feng Shen: Establishing a New Front in Liver Cancer Prevention and Treatment with the Liver Tumor Committee
From October 24 to 27, 2024, the 9th Academic Symposium of the Chinese Division of the International Hepato-Pancreato-Biliary Association (IHPBA) was held in Wuhan. Experts discussed pressing issues and innovations in hepatobiliary and pancreatic surgery, exchanging diagnostic and treatment experiences, promoting new ideas and techniques, and advancing the management of hepatobiliary diseases in China. During…
-
ILCA 2024 | Dr. Lin Zhang: New Perspectives in Liver Cancer Treatment – The Impact of Immune Microenvironment on SIRT Efficacy
Selective Internal Radiation Therapy (SIRT) is a validated treatment for liver cancer, yet the influence of the immune microenvironment on treatment response and survival remains unclear. At the 18th International Liver Cancer Association (ILCA) Annual Conference, a recent study shed light on the complex relationship between the immune microenvironment in liver cancer patients prior to…
-
Dr. Jie Xu: Advancing Empirical Treatment Strategies for Febrile Neutropenia
Febrile neutropenia is a significant concern among immunocompromised patients due to the high infection-related mortality if left untreated. At the recent 4th Shanghai Symposium on Clinical Application of Autologous Hematopoietic Stem Cell Transplantation, Dr. Jie Xu of Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, discussed new empirical treatment approaches. This article consolidates…
-
Chairman’s Interview | Dr. Shuangsuo Dang: Ten Years on the Road, Exploring New Trends in Hepatology in the Western Regions
Hepatology Digest: This is the 10th “Silk Road Hepatology” Academic Conference. Could you take us through the journey of the past ten years? Dr. Shuangsuo Dang: The “Silk Road Hepatology”…
-
Dr. Tao Chen: Insights on the “Expert Consensus on Thymosin Alpha-1 in Infectious Diseases and Critical Illness” | CCIFLDI 2024
Overview of Thymosin Alpha-1 (Tα1) Thymosin Alpha-1 (Tα1), also known as thymic peptide α1, was initially isolated from calf thymus and is expressed in humans with an identical sequence. Tα1…
Connecting Medical Expertise through Media